Phase 2 Prostate Cancer Trial, Recruiting (NCT06865768)

Phase 2 Prostate Cancer Trial, Recruiting NCT06865768 Sponsor: Emory University Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06865768 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are male and over 18 years old
You have a suspected prostate cancer diagnosis and are already scheduled to have a prostate biopsy to confirm this
You are able to lie still during an MRI scan
You are willing and able to sign a written consent form to participate

Who may not be able to join:

You currently have acute prostatitis (prostate infection), significant urinary problems related to a non-cancerous enlarged prostate, or a urinary tract infection
You have a medical implant that is not compatible with MRI scanning, such as a pacemaker or cochlear (ear) implant
You have a hip replacement on one or both sides
You have other serious health conditions that would make having a prostate biopsy too risky, or that might affect your ability to complete the trial (confirm with trial site)
You have had a prostate biopsy within the last 4 weeks, as any resulting inflammation could affect the scan results
The doctor running the trial decides that the trial is not medically appropriate for you
You are not able to understand the language in which the patient information is provided
You are currently taking part in another clinical trial, or have done so within the past 30 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: David M Schuster, MD, FACR, Emory University Hospital/Winship Cancer Institute

Phone: 404-712-4859

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06865768

Sponsor: Emory University

Phase: Phase 2

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 404-712-4859

More information: https://clinicaltrials.gov/study/NCT06865768

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are male and over 18 years old
You have a suspected prostate cancer diagnosis and are already scheduled to have a prostate biopsy to confirm this
You are able to lie still during an MRI scan
You are willing and able to sign a written consent form to participate

Who may not be able to join:

You currently have acute prostatitis (prostate infection), significant urinary problems related to a non-cancerous enlarged prostate, or a urinary tract infection
You have a medical implant that is not compatible with MRI scanning, such as a pacemaker or cochlear (ear) implant
You have a hip replacement on one or both sides
You have other serious health conditions that would make having a prostate biopsy too risky, or that might affect your ability to complete the trial (confirm with trial site)
You have had a prostate biopsy within the last 4 weeks, as any resulting inflammation could affect the scan results
The doctor running the trial decides that the trial is not medically appropriate for you
You are not able to understand the language in which the patient information is provided
You are currently taking part in another clinical trial, or have done so within the past 30 days

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Emory University

Registry

ClinicalTrials.gov

Start date

18 April 2025

Est. completion

31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Discrimination of clinically significant prostate cancer (csPCa) from non-csPCa

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov